WHO ICTRP trial
A comparative study of insulin combined with SGLT2 inhibitors/metformin in newly…
ChiCTR2600116249 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600116249 |
|---|---|
| Public title | A comparative study of insulin combined with SGLT2 inhibitors/metformin in newly diagnosed type 2 diabetes patients |
| Scientific title | A comparative study of insulin combined with SGLT2 inhibitors/metformin in newly diagnosed type 2 diabetes patients |
| Primary sponsor | Tianjin Medical University Chu Hsien-I Memorial Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | diabetes |
| Interventions | The group receiving only insulin:Only using insulin-based medications (such as rapid-acting, premixed, long-acting insulins, etc.) for blood sugar control, without combining other types of hypoglycemic drugs (such as metformin, SGLT-2… |
| Registration date | Jan 7, 2026 |
| Target size | The group receiving only insulin:30;The group treated with metformin and… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: